Drug Profile
HLD 400
Alternative Names: HLD400Latest Information Update: 28 May 2019
Price :
$50
*
At a glance
- Originator Highland Therapeutics
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Inflammatory bowel diseases
Most Recent Events
- 28 May 2019 No recent reports of development identified for clinical-Phase-Unknown development in Inflammatory-bowel-diseases in Unknown
- 26 May 2016 Highland Therapeutics plans a phase I trial for Inflammatory bowel disease
- 26 Apr 2016 Clinical development for Inflammatory bowel disease (unspecified route) before April 2016 (Highland Therapeutics pipeline, April 2016)